Global Human Papillomavirus Vaccine Market | CAGR 6.18%

The Global Human Papillomavirus Vaccine Market to grow from USD 3,256.24 Million in 2018 to USD 4,956.24 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.18%. Some of the major market players include Bayer AG, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., and Pfizer Inc..

360iResearch Logo
Global Human Papillomavirus Vaccine Market | CAGR 6.18%
Report Code: PH-9517C78 | Publishing Date: August 2019 | Number of Pages: 113
Global Human Papillomavirus Vaccine Market | CAGR 6.18%

Company Usability Profiles:

The global human papillomavirus vaccine market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global human papillomavirus vaccine market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Bayer AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • EyeGene Inc.
  • Inovio Pharmaceuticals Inc.
  • Mayo Clinic
  • Merck Sharp & Dohme Corp
  • Nuron Biotech Inc.
  • Planned Parenthood Federation of America Inc.
  • Sanofi S.A.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Human Papillomavirus Vaccine Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY INDICATION
    • Anal Cancer
    • Cervical Cancer
    • Genital Warts
    • Oropharyngeal Cancer
    • Penile Cancer
    • Vaginal Cancer
    • Vulvar Cancer
  • GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY VALANCE
    • Bivalent
    • Quadrivalent and Nonavalent
  • GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY DISTRIBUTION CHANNEL
    • Government Entities
    • Physician Distributors
    • Physicians
    • Public and Private Alliances
    • Wholesalers
  • GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • South Korea
      • Thailand
    • Europe, Middle East & Africa
      • Denmark
      • France
      • Germany
      • Italy
      • Netherlands
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • United Arab Emirates
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Human Papillomavirus Vaccine Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Human Papillomavirus Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Human Papillomavirus Vaccine Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Human Papillomavirus Vaccine Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Human Papillomavirus Vaccine Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Human Papillomavirus Vaccine Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Human Papillomavirus Vaccine Market .
  • Evaluate the key vendors in the Global Human Papillomavirus Vaccine Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Market Data Feed
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increasing prevalence of various cancers and STDs caused by human papillomavirus
        2. Government support & initiatives
      2. Restraints
        1. Expensive price 0f vaccine
        2. Limited clinical trials and acceptability
      3. Opportunities
        1. Incentives for vaccine derived from related indications
        2. R&D developments in human papillomavirus vaccines and medication
      4. Challenges
        1. Concerns over the safety of the HPV vaccine
    3. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Client Customizations
      1. Clinical Trials & Trends
      2. Pricing Analysis & Trend
  5. Global Human Papillomavirus Vaccine Market, by Indication
    1. Overview
    2. Market Sizing & Forecasting
    3. Anal Cancer
    4. Cervical Cancer
    5. Genital Warts
    6. Oropharyngeal Cancer
    7. Penile Cancer
    8. Vaginal Cancer
    9. Vulvar Cancer
  6. Global Human Papillomavirus Vaccine Market, by Valance
    1. Overview
    2. Market Sizing & Forecasting
    3. Bivalent
    4. Quadrivalent and Nonavalent
  7. Global Human Papillomavirus Vaccine Market, by Distribution Channel
    1. Overview
    2. Market Sizing & Forecasting
    3. Government Entities
    4. Physician Distributors
    5. Physicians
    6. Public and Private Alliances
    7. Wholesalers
  8. Global Human Papillomavirus Vaccine Market, by Geography
    1. Overview
    2. Market Sizing & Forecasting
    3. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Chile
      5. Mexico
      6. United States
    4. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    5. Europe, Middle East & Africa
      1. Denmark
      2. France
      3. Germany
      4. Italy
      5. Netherlands
      6. Qatar
      7. Russia
      8. Saudi Arabia
      9. South Africa
      10. Spain
      11. United Arab Emirates
      12. United Kingdom
  9. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
        1. Forefront
        2. Pathfinders
        3. Niche
        4. Vital
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  10. Company Usability Profiles
    1. Bayer AG
      1. Overview
      2. Strategy
      3. SWOT
    2. GlaxoSmithKline plc.
      1. Overview
      2. Strategy
      3. SWOT
    3. Johnson & Johnson
      1. Overview
      2. Strategy
      3. SWOT
    4. Merck & Co., Inc.
      1. Overview
      2. Strategy
      3. SWOT
    5. Pfizer Inc.
      1. Overview
      2. Strategy
      3. SWOT
    6. EyeGene Inc.
    7. Inovio Pharmaceuticals Inc.
    8. Mayo Clinic
    9. Merck Sharp & Dohme Corp
    10. Nuron Biotech Inc.
    11. Planned Parenthood Federation of America Inc.
    12. Sanofi S.A.
  11. Appendix
    1. Discussion Guide
    2. Author Details

List of Tables

  1. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  4. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY ANAL CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY CERVICAL CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GENITAL WARTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY OROPHARYNGEAL CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PENILE CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VAGINAL CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VULVAR CANCER, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  12. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY BIVALENT, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY QUADRIVALENT AND NONAVALENT, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  15. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GOVERNMENT ENTITIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  17. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PHYSICIANS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY PUBLIC AND PRIVATE ALLIANCES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  19. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY WHOLESALERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  20. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  21. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  22. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  23. AMERICAS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  24. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  25. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  26. ARGENTINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  27. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  28. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  29. BRAZIL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  30. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  31. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  32. CANADA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  33. CHILE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  34. CHILE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  35. CHILE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  36. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  37. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  38. MEXICO HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  39. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  40. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  41. UNITED STATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  42. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  43. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  44. ASIA-PACIFIC HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  45. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  46. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  47. AUSTRALIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  48. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  49. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  50. CHINA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  51. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  52. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  53. INDIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  54. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  55. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  56. INDONESIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  57. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  58. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  59. JAPAN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  60. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  61. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  62. MALAYSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  63. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  64. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  65. PHILIPPINES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  66. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  67. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  68. SOUTH KOREA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  69. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  70. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  71. THAILAND HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  72. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  73. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  74. EUROPE, MIDDLE EAST & AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  75. DENMARK HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  76. DENMARK HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  77. DENMARK HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  78. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  79. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  80. FRANCE HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  81. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  82. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  83. GERMANY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  84. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  85. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  86. ITALY HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  87. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  88. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  89. NETHERLANDS HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  90. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  91. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  92. QATAR HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  93. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  94. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  95. RUSSIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  96. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  97. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  98. SAUDI ARABIA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  99. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  100. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  101. SOUTH AFRICA HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  102. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  103. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  104. SPAIN HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  105. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  106. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  107. UNITED ARAB EMIRATES HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  108. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  109. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2016-2025 (USD MILLION)
  110. UNITED KINGDOM HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  111. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RANKING
  112. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: AUTHOR DETAILS

List of Figures

  1. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RESEARCH PROCESS
  2. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: RESEARCH FRAMEWORK
  3. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: FORECASTING METHODOLOGY
  4. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: MARKET CONNECTIVITY
  6. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: MARKET DYNAMICS
  7. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  8. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2018 VS 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  10. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2018 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY VALANCE, 2025 (USD MILLION)
  12. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 (USD MILLION)
  14. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  16. GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET: FPNV POSITIONING MATRIX
  17. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY NEWS TYPE
  18. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY COMPANY
  19. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL HUMAN PAPILLOMAVIRUS VACCINE MARKET, BY YEAR
  1. Bayer AG
  2. GlaxoSmithKline plc.
  3. Johnson & Johnson
  4. Merck & Co., Inc.
  5. Pfizer Inc.
  6. EyeGene Inc.
  7. Inovio Pharmaceuticals Inc.
  8. Mayo Clinic
  9. Merck Sharp & Dohme Corp
  10. Nuron Biotech Inc.
  11. Planned Parenthood Federation of America Inc.
  12. Sanofi S.A.
Global Human Papillomavirus Vaccine Market
Report Code
PH-9517C78
Publishing Date
August 2019
Number of Pages
113
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $5449
CORPORATE USER LICENSE $4449
SINGLE USER LICENSE $3449
WEB PACK LICENSE $2949
DATA PACK LICENSE $1749

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.